Accessibility Tools
 Inflammasome Therapeutics - Hong Guo, Ph.D.

Hong Guo, Ph.D.

Vice President, Development

Dr. Guo has made significant contributions to the design and development of three FDA-approved, sustained-release, intravitreal implantable and injectable products. She brings over 25 years of experience developing drug products from early feasibility through clinical development and commercialization, spanning formulation, analytical development, ocular delivery, preclinical research, and regulatory submission.